SCHEMBL3846594

SCHEMBL3846594

CCOC(=O)c1ccc(-c2nn(C(c3ccccc3)(c3ccccc3)c3ccccc3)cc2-c2ccc3ncc(-c4ccccn4)n3c2)cc1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
JMJD6 Q6NYC1 3/20 0.42
TGFBR1 P36897 6/20 0.39
TGFBR2 P37173 1/20 0.39
NPC1 O15118 2/20 0.39
RAB9A P51151 2/20 0.39
MEN1 O00255 1/20 0.39
KMT2A Q03164 1/20 0.39
METAP1 P53582 1/20 0.38
AKT1 P31749 1/20 0.38
AKT2 P31751 1/20 0.38
MAOB P27338 1/20 0.38
DYRK3 O43781 1/20 0.38
CCNT1 O60563 1/20 0.38
CCNA2 P20248 1/20 0.38
CDK2 P24941 1/20 0.38
CDK9 P50750 1/20 0.38
CDK5 Q00535 1/20 0.38
DYRK1A Q13627 1/20 0.38
CDK5R1 Q15078 1/20 0.38
DYRK2 Q92630 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3845039 0.92 TGFBR1 (0.46) TGFBR1TGFBR2AKT1AKT2
SCHEMBL3847225 0.88 TGFBR1 (0.43) TGFBR1TGFBR2
SCHEMBL3846841 0.87 TGFBR1 (0.48) TGFBR1TGFBR2AKT1AKT2
SCHEMBL4712454 0.87 TGFBR1 (0.39) TGFBR1TGFBR2
SCHEMBL3850395 0.84 TGFBR1 (0.38) TGFBR1TGFBR2NPC1RAB9AMEN1
SCHEMBL3857417 0.84 TGFBR1 (0.42) TGFBR1TGFBR2CYP2C9
SCHEMBL3852272 0.84 TGFBR1 (0.41) TGFBR1TGFBR2NPC1RAB9A
SCHEMBL3849790 0.83 AKT1 (0.37) JMJD6TGFBR1NPC1RAB9AAKT1
SCHEMBL3846122 0.83 FYN (0.42) TGFBR1TGFBR2AKT1AKT2
SCHEMBL3846170 0.83 TGFBR1 (0.46) TGFBR1TGFBR2NPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2048142-A2 Nitrogen-containing condensed cyclic compound having a pyrazolyl group as a substituent group and pharmaceutical composition thereof Eisai R&D Management Co., Ltd. (JP) 2009-04-15 EP disclosed
EP-1382603-B1 NITROGENOUS FUSED-RING COMPOUND HAVING PYRAZOLYL GROUP AS SUBSTITUENT AND MEDICINAL COMPOSITION THEREOF EISAI R&D MAN CO LTD (JP) 2008-07-23 EP disclosed
US-7074801-B1 Nitrogen-containing condensed cyclic compound having a pyrazolyl group as a substituent group and pharmaceutical composition thereof EISAI CO., LTD. (JP) 2006-07-11 US disclosed
EP-1382603-A1 NITROGENOUS FUSED−RING COMPOUND HAVING PYRAZOLYL GROUP AS SUBSTITUENT AND MEDICINAL COMPOSITION THEREOF Eisai Co., Ltd. (JP) 2004-01-21 EP disclosed